Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil for anesthesia in day hysteroscopic endometrial polypectomy
ChiCTR2400086565Phase 4Completed
- Sponsor
- Weifang Maternal and Child Health Care Hospital
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine and sufentanil in endometrial polyp (2 arms), sponsored by Weifang Maternal and Child Health Care Hospital. Primary endpoints: Malondialdehyde, Tumor necrosis factor-alpha and 2 more. Started Jul 2024; status: completed.
02
Drugs
nalbuphinesufentanil
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on ChiCTR2400086565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086565.